LigaChem Biosciences Inc (141080) Stock Price & News

141080:KOSDAQ

LigaChem Biosciences Inc

₩62,200.00

-1.58%

(-1,000.00) 1D

Nov 13, 3:30:18 PM GMT+9 · KRW

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 141080...

Open

₩63,900

High

₩68,200

Low

₩61,800

Mkt. cap

2.30T

Avg. vol.

230.54K

Volume

212.21K

52-wk high

₩225,000

52-wk low

₩54,100

EPS

-₩4,887

Shares outstanding

37.03M

No. of employees

183

Open

₩63,900

High

₩68,200

Low

₩61,800

Mkt. cap

2.30T

Avg. vol.

230.54K

Volume

212.21K

52-wk high

₩225,000

52-wk low

₩54,100

EPS

-₩4,887

Shares outstanding

37.03M

No. of employees

183

Related stocks

PharmaResearch Co Ltd

News stories

From web sources and news partners

Yahoo Finance

1 hour ago

The S&P 500 Has Gone 18 Months Without a 10% Drop. Here's How the Next Year Has Gone After Streaks This Long.

Bloomberg.com

4 hours ago

SpaceX’s S&P 500 Bid Gets New Life as Musk Pitches Tesla Merger

The Motley Fool

2 hours ago

Prediction: This Small-Cap Value ETF Will Beat the S&P 500 Over the Next 10 Years

Traders Union

2 hours ago

Tom McClellan: NYSE Composite Index better comparison for A-D Line than S&P 500

About LigaChem Biosciences Inc

CEOYong Zu Kim

Employees183

Founded2006

Headquarters-

SectorHealth Care

Industry-

Websiteligachembio.com

All values in KRW	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	41.41B	15.95B	35.89B	5.53B
Cost of goods sold	3.77B	3.74B	2.35B	2.37B
Cost of revenue	3.77B	3.74B	2.35B	2.37B
Research and development expenses	57.24B	82.42B	67.36B	69.71B
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	3.15B	2.93B	3.85B	5.33B
Operating expense	60.83B	85.33B	70.96B	75.14B
Total operating expenses	64.61B	89.07B	73.31B	77.51B
Operating income	-23.20B	-73.12B	-37.42B	-71.98B
Other non operating income	-15.30M	28.48M	28.52M	352.54M
EBT including unusual items	-15.34B	-66.93B	-34.27B	-68.05B
EBT excluding unusual items	-15.48B	-66.88B	-34.25B	-68.86B
Income tax expense	125.31K	-2.33B	-959.99M	68.18M
Effective tax rate	-	3.48%	2.80%	-0.10%
Other operating expenses	-	-	-	-
Net income	-15.63B	-54.57B	-37.33B	-71.20B
Net profit margin	-37.75%	-342.10%	-104.02%	-1,286.86%
Earnings per share	-431.00	-1.49K	-1.02K	-1.93K
Interest and investment income	4.29B	4.13B	3.59B	3.41B
Interest expense	106.33M	-769.59M	-725.45M	-749.43M
Net interest expenses	4.40B	3.36B	2.86B	2.66B
Depreciation and amortization charges	96.87M	86.81M	83.28M	82.75M
EBITDA	-21.65B	-70.97B	-35.88B	-70.39B
Gain or loss from assets sale	-105.00K	-221.00K	-2.11M	-6.43M

Ask anything